These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 8973882

  • 1. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.
    Nicolucci A, Carinci F, Cavaliere D, Scorpiglione N, Belfiglio M, Labbrozzi D, Mari E, Benedetti MM, Tognoni G, Liberati A.
    Diabet Med; 1996 Dec; 13(12):1017-26. PubMed ID: 8973882
    [Abstract] [Full Text] [Related]

  • 2. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
    Karsidag S, Morali S, Sargin M, Salman S, Karsidag K, Us O.
    Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The efficacy of tolrestat in the treatment of diabetic peripheral neuropathy. A meta-analysis of individual patient data.
    Nicolucci A, Carinci F, Graepel JG, Hohman TC, Ferris F, Lachin JM.
    Diabetes Care; 1996 Oct; 19(10):1091-6. PubMed ID: 8886554
    [Abstract] [Full Text] [Related]

  • 5. Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy.
    Airey M, Bennett C, Nicolucci A, Williams R.
    Cochrane Database Syst Rev; 2000 Oct; 1996(2):CD002182. PubMed ID: 10796870
    [Abstract] [Full Text] [Related]

  • 6. [Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement].
    Shimada H, Miki T, Kyogoku I, Kawagishi T, Inaba M, Okuno Y, Nishizawa Y, Morii H.
    No To Shinkei; 1998 Sep; 50(9):817-20. PubMed ID: 9789304
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.
    Bril V, Buchanan RA.
    Diabetes Care; 2006 Jan; 29(1):68-72. PubMed ID: 16373898
    [Abstract] [Full Text] [Related]

  • 8. Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy.
    Valensi P, Attali JR, Gagant S.
    Diabet Med; 1993 Dec; 10(10):933-9. PubMed ID: 8306589
    [Abstract] [Full Text] [Related]

  • 9. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.
    Uluc K, Isak B, Borucu D, Temucin CM, Cetinkaya Y, Koytak PK, Tanridag T, Us O.
    Clin Neurophysiol; 2008 Apr; 119(4):880-5. PubMed ID: 18291716
    [Abstract] [Full Text] [Related]

  • 10. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes.
    Jarmuzewska EA, Mangoni AA.
    J Intern Med; 2005 Jul; 258(1):38-44. PubMed ID: 15953131
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2007 Jul; 64(6):423-30. PubMed ID: 18159852
    [Abstract] [Full Text] [Related]

  • 12. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
    Kawai T, Takei I, Tokui M, Funae O, Miyamoto K, Tabata M, Hirata T, Saruta T, Shimada A, Itoh H.
    J Diabetes Complications; 2010 Jul; 24(6):424-32. PubMed ID: 19716319
    [Abstract] [Full Text] [Related]

  • 13. Neuropathy patterns differ in patients with diabetic complications.
    Kiziltan ME, Benbir G.
    Electromyogr Clin Neurophysiol; 2008 Jul; 48(8):351-7. PubMed ID: 19097475
    [Abstract] [Full Text] [Related]

  • 14. Diabetic neuropathy: a clinical, laboratory and electrodiagnostic study.
    Halar EM, Graf RJ, Halter JB, Brozovich FV, Soine TL.
    Arch Phys Med Rehabil; 1982 Jul; 63(7):298-303. PubMed ID: 7092528
    [Abstract] [Full Text] [Related]

  • 15. Diabetic peripheral neuropathy: a correlation of nerve conduction studies and clinical findings.
    Braddom RL, Hollis JB, Castell DO.
    Arch Phys Med Rehabil; 1977 Jul; 58(7):308-13. PubMed ID: 880006
    [Abstract] [Full Text] [Related]

  • 16. Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients.
    Kassem HS, Azar ST, Zantout MS, Sawaya RA.
    Neuro Endocrinol Lett; 2005 Dec; 26(6):775-9. PubMed ID: 16380709
    [Abstract] [Full Text] [Related]

  • 17. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ, MBBQ Study Group.
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [Abstract] [Full Text] [Related]

  • 18. Ranirestat for the management of diabetic sensorimotor polyneuropathy.
    Bril V, Hirose T, Tomioka S, Buchanan R, Ranirestat Study Group.
    Diabetes Care; 2009 Jul; 32(7):1256-60. PubMed ID: 19366965
    [Abstract] [Full Text] [Related]

  • 19. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
    Ramirez MA, Borja NL.
    Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
    [Abstract] [Full Text] [Related]

  • 20. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.
    Shimoshige Y, Ikuma K, Yamamoto T, Takakura S, Kawamura I, Seki J, Mutoh S, Goto T.
    Metabolism; 2000 Nov; 49(11):1395-9. PubMed ID: 11092500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.